1. Home
  2. Analysis
  3. Abraxane
  4. Folate

Abraxane and Folate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abraxane (paclitaxel) and Folate (folic acid). Common drug interactions include death among females and large intestine perforation among males.

The phase IV clinical study analyzes what interactions people have when they take Abraxane and Folate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

What is Folate?

Folate has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 6,546 Folate users. Check the latest studies of Folate.

On Jul, 12, 2026

12 people who take Abraxane and Folate together, and have interactions are studied.

Abraxane and Folate drug interactions.

What are the common drug interactions of Abraxane and Folate, by gender? *:

female:

  1. Death
  2. Diarrhoea
  3. Anxiety
  4. Back pain

male:

  1. Large intestine perforation (hole in large intestine)
  2. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  3. General physical health deterioration (weak health status)
  4. Pain
  5. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

What are the common drug interactions of Abraxane and Folate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Back pain
  3. Death
  4. General physical health deterioration (weak health status)
  5. Pain

60+:

  1. Large intestine perforation (hole in large intestine)
  2. Diarrhoea
  3. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  4. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 33.33%
  2. Iron Deficiency Anaemia: 4 people, 33.33%
  3. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 4 people, 33.33%
  4. Gastric Ulcer (stomach ulcer): 4 people, 33.33%
  5. Fungal Infection: 4 people, 33.33%
  6. Folate Deficiency (lack of folic acid): 4 people, 33.33%
  7. High Blood Pressure: 3 people, 25.00%
  8. Diabetes: 3 people, 25.00%
  9. Nausea (feeling of having an urge to vomit): 2 people, 16.67%
  10. Metastases To Liver (cancer spreads to liver): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Abraxane and Folate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abraxane and Folate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abraxane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Folate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abraxane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Folate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel and folic acid (the active ingredients of Abraxane and Folate, respectively), and Abraxane and Folate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.